Ara
Toplam kayıt 2, listelenen: 1-2
Rituximab Treatment In Children With Difficult-To-Treat Nephrotic Syndrome
(2022)
Purpose: Rituximab (RTX) has been offered as rescue therapy for patients with difficult-to-treat nephrotic syndrome (frequent relapsing, steroid-dependent and steroid resistant). We aimed to assess the efficacy and long-term ...
Transplantation in pediatric aHUS within the era of eculizumab therapy
(2020)
aHUS is caused by the over-activation and dysregulation of the alternative complement pathway. Data regarding outcomes of pediatric aHUS patients after kidney transplantation are still very scarce. Accordingly, the aim of ...